Literature DB >> 1339823

Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle.

S C Koh1, P C Wong, R Yuen, S E Chua, B L Ng, S S Ratnam.   

Abstract

The concentrations of tissue plasminogen activator (t-PA), urokinase plasminogen activator (u-PA) and plasminogen activator inhibitor (PAI-1) have been determined in endometrial curettings obtained from 46 subfertile women during proliferative, early or late secretory phases of the menstrual cycle. t-PA activity and antigen concentrations was significantly higher (P < 0.001) in late secretory endometrium than in proliferative or early secretory endometrium. Higher concentrations of PAI-1 antigen (P < 0.05) were also noted in late secretory phase than in proliferative and early secretory endometrium. However, u-PA concentration was not significantly different and no PAI activity could be demonstrated in the menstrual phases studied. Zymography studies confirmed the presence of both t-PA and u-PA in the endometrium. Ovarian hormonal patterns may therefore influence the activity of plasminogen activators especially of t-PA in the endometrium during various phases of the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339823     DOI: 10.1530/jrf.0.0960407

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  6 in total

1.  The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual Cycles.

Authors:  Esra Demirel; Reem Sabouni; Neelima Chandra; Ov D Slayden; David F Archer
Journal:  Reprod Sci       Date:  2021-11-18       Impact factor: 3.060

2.  Testosterone upregulation of tissue type plasminogen activator expression in Sertoli cells : tPA expression in Sertoli cells.

Authors:  Jian Guo; Yu-Qiang Shi; Wei Yang; Yin-Chuan Li; Zhao-Yuan Hu; Yi-Xun Liu
Journal:  Endocrine       Date:  2007-10-09       Impact factor: 3.633

3.  SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase.

Authors:  Robert Kuo-Kuang Lee; Chi-Chen Fan; Yuh-Ming Hwu; Chung-Hao Lu; Ming-Huei Lin; Ying-Jie Chen; Sheng-Hsiang Li
Journal:  Reprod Biol Endocrinol       Date:  2011-03-23       Impact factor: 5.211

Review 4.  Endometrial haemostasis and menstruation.

Authors:  Joanna Davies; Rezan A Kadir
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

5.  Serum estradiol levels in controlled ovarian stimulation directly affect the endometrium.

Authors:  Kamran Ullah; Tanzil Ur Rahman; Hai-Tao Pan; Meng-Xi Guo; Xin-Yan Dong; Juan Liu; Lu-Yang Jin; Yi Cheng; Zhang-Hong Ke; Jun Ren; Xian-Hua Lin; Xiao-Xiao Qiu; Ting-Ting Wang; He-Feng Huang; Jian-Zhong Sheng
Journal:  J Mol Endocrinol       Date:  2017-05-24       Impact factor: 5.098

6.  A complex of novel protease inhibitor, ovostatin homolog, with its cognate proteases in immature mice uterine luminal fluid.

Authors:  Hsien-Lu Huang; Szu-Chin Li; Jin-Fong Wu
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.